The effectiveness of paclitaxel (Taxol) in a range of tumors has been established in a large number of trials. In non–small-cell lung cancer, paclitaxel combined with cisplatin (Platinol) has been shown to be highly effective.
Paris A. Kosmidis, MD
Advertisement
Articles by Paris A. Kosmidis, MD
Advertisement
Latest Updated Articles
- The Safety of Paclitaxel/Platinum Combinations
Published: September 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
3
Career Stage and Location Found to Impact Oncology Coverage in the US
4
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
5
